
Jane B. Neckers
- Center for Cancer Research
- National Cancer Institute
- Building 10 - Magnuson CC, Room 12N230
- Bethesda, MD 20892
- 240-760-6330
- trepelj@mail.nih.gov
RESEARCH SUMMARY
Jane Neckers came to the NCI from the Laboratory of Preclinical Pharmacology, National Institute of Mental Health, where she identified posttranslational modification of glycoprotein hormones by ADP-ribosylation. Since then she has held positions of increasing responsibility in the former Clinical Pharmacology Branch and Medicine Branch. She is the author of five issued and pending patents in new drug development and is the recipient of a Federal Technology Transfer Award. Her interests are focused on the new therapeutic opportunities provided by molecular dissection of aberrant tumor cell signaling pathways.
Areas of Expertise
1) drug development

Jane B. Neckers
Publications
Posttranslational modification and conformational state of Heat Shock Protein 90 differentially affect binding of chemically diverse small molecule inhibitors
A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma
Asymmetric Hsp90 N domain SUMOylation recruits Aha1 and ATP-competitive inhibitors
Contributions of co-chaperones and post-translational modifications towards Hsp90 drug sensitivity
Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis
Biography

Jane B. Neckers
Jane Neckers came to the NCI from the Laboratory of Preclinical Pharmacology, National Institute of Mental Health, where she identified posttranslational modification of glycoprotein hormones by ADP-ribosylation. Since then she has held positions of increasing responsibility in the former Clinical Pharmacology Branch and Medicine Branch. She is the author of five issued and pending patents in new drug development and is the recipient of a Federal Technology Transfer Award. Her interests are focused on the new therapeutic opportunities provided by molecular dissection of aberrant tumor cell signaling pathways.